Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 16, 04 December 2023
Open
Access | Article
Current materials used in artificial vascular tissue engineering
* Author to whom correspondence should be addressed.
Abstract
A commonly employed approach in the field of vascular tissue regeneration involves the utilization of artificial vascular tissue implants. These implants are designed to replicate the natural architecture of blood vessels through the use of artificial scaffolds, followed by cell growth induced onto these scaffolds, which are subsequently introduced into the body to replace damaged blood tissue. One of the primary obstacles encountered in implementing this technique pertains to the selection of materials that most nearly mimic the characteristics of naturally occurring tissue. Specifically, the aim is to develop an artificial device that closely emulates the biological functionality while eliciting minimal immunological reaction. A wide range of materials for constructing scaffolds has been extensively documented, encompassing natural, synthetic, and composite materials, as well as decellularized extracellular matrix. This study aims to conduct a comprehensive analysis of the existing literature in the field of vascular tissue engineering, utilizing methods of literature review and analysis. The examination will focus on evaluating the strengths, flaws, and availability of the available resources in this area of research.
Keywords
Blood Vessel Engineering, Material, Scaffold, Extracellular Matrix
References
1. Hu K, Li Y, Ke Z, Yang H, Lu C, Li Y, Guo Y, Wang W. History, progress and future challenges of artificial blood vessels: a narrative review. Biomater Transl. 2022 Mar 28;3(1):81-98. doi: 10.12336/biomatertransl.2022.01.008. PMID: 35837341; PMCID: PMC9255792.
2. Bakey M, Cooley D. Sucessful resection of aneurysm of distal aortic arch and replacement by graft. J Am Med Assoc. (1954) 155:1398–403. doi: 10.1001/jama.1954.03690340020007
3. Michel R. Hoenig , Gordon R. Campbell , Barbara E. Rolfe , and Julie H. Campbell. Tissue-Engineered Blood VesselsAlternative to Autologous Grafts? Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1128–1134
4. Devillard, C. D., & Marquette, C. A. Vascular Tissue Engineering: Challenges and requirements for an ideal large scale blood vessel. Frontiers. 2021, Volume 9, Sec. Regenerative Medicine
5. Thottappillil N, Nair PD. Scaffolds in vascular regeneration: current status. Vasc Health Risk Manag. 2015 Jan 19;11:79-91. doi: 10.2147/VHRM.S50536. PMID: 25632236; PMCID: PMC4304530.
6. Leal, B. B. J., Wakabayashi, N., Oyama, K., Kamiya, H., Braghirolli, D. I., & Pranke, P. Vascular Tissue Engineering: Polymers and methodologies for small caliber vascular grafts. Frontiers. 2021, Volume 7, Sec.Cardiovascular Biologics and Regenerative Medicine
7. Xu CY, Inai R, Kotaki M, Ramakrishna S. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. Biomaterials. 2004 Feb;25(5):877-86. doi: 10.1016/s0142-9612(03)00593-3. PMID: 14609676.
8. Eble JA, Niland S. The extracellular matrix of blood vessels. Curr Pharm Des. 2009;15(12):1385-400. doi: 10.2174/138161209787846757. PMID: 19355976.
9. Villalona GA, Udelsman B, Duncan DR, McGillicuddy E, Sawh-Martinez RF, Hibino N, Painter C, Mirensky T, Erickson B, Shinoka T, Breuer CK. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev. 2010 Jun;16(3):341-50. doi: 10.1089/ten.TEB.2009.0527. PMID: 20085439; PMCID: PMC2946885.
10. Ferry P.W. Melchels, Ana M.C. Barradas, Clemens A. van Blitterswijk, Jan de Boer, Jan Feijen, Dirk W. Grijpma, Effects of the architecture of tissue engineering scaffolds on cell seeding and culturing, Acta Biomaterialia, Volume 6, Issue 11, 2010, Pages 4208-4217
11. lex P. Rickel, Xiajun Deng, Daniel Engebretson, Zhongkui Hong, Electrospun nanofiber scaffold for vascular tissue engineering, Materials Science and Engineering: C, 2021, Volume 129, 112373
12. Ravi S, Chaikof EL. Biomaterials for vascular tissue engineering. Regen Med. 2010 Jan;5(1):107-20. doi: 10.2217/rme.09.77. PMID: 20017698; PMCID: PMC2822541.
13. Yao Y, Wang J, Cui Y, Xu R, Wang Z, Zhang J, Wang K, Li Y, Zhao Q, Kong D. Effect of sustained heparin release from PCL/chitosan hybrid small-diameter vascular grafts on anti-thrombogenic property and endothelialization. Acta Biomater. 2014 Jun;10(6):2739-49.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-195-7
- ISBN (Online)
- 978-1-83558-196-4
- Published Date
- 04 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/16/20240530
- Copyright
- 04 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited